U.S. flag An official website of the United States government
  1. Home
  2. About FDA
  3. FDA Organization
  4. Office of the Commissioner
  5. Office of the Chief Scientist
  6. National Center for Toxicological Research
  7. Science & Research (NCTR)
  8. Svetoslav Slavov
  1. Science & Research (NCTR)

Svetoslav Slavov Ph.D.

Research Chemist — Division of Systems Biology

No photo available


Svetoslav Slavov, Ph.D.
(870) 543-7121
NCTRResearch@fda.hhs.gov  

Back to NCTR Principal Investigators page


About  |  Publications 


Background

Dr. Svetoslav Slavov holds a Ph.D. in molecular design from the University of Tartu, Estonia. He is a molecular modeling expert working exclusively in the fields of quantitative structure-activity relationships (QSAR) modeling, molecular design and, computational toxicology. Dr. Slavov is an author of 40 research papers (a first author for 19 of them) and a book chapter in the field of QSAR/quantitative structure-property relationship (QSPR) and drug design. His major contributions to the fields of chem- and bio- informatics include the development of new modeling approaches and validation techniques as well as the discovery of new algorithms for structural/mechanistic interpretation of QSAR models. Information on his research was reported on National Public Radio, The New York Times, Fox News, ABC6, Medical News Today, and the Daily Telegraph . Within the Division of Systems Biology, his research is focused on the development of new computational toxicology approaches and models that can supplement the regulatory decisions and shorten the review process for new Investigational New Drug Applications(IND), by substituting the lengthy and expensive animal testing with reliable and accurate estimates of various safety endpoints. He has also worked on projects for biomarker and bacteria identification developing advanced algorithms for feature extraction and pattern identification. In 2015 and 2018 Dr. Slavov was awarded the FDA “Chief Scientist’s Publication Award for Data Methods/Analysis/Study Design.”

Research Interests

  • Molecular Modeling
  • QSAR/QSPR
  • Drug Design
  • Computational Toxicology
  • Statistics
  • Quantum Mechanics
  • Quantum Field Theory

Selected Publications

Quantitative Structure-Toxicity Relationships in Translational Toxicology.
Slavov S. and Beger R.D.
Current Opinion in Toxicology. 2020, 23:46

Determination of Structural Factors Affecting Binding to Mu, Kappa and Delta Opioid Receptors.
Slavov S., Mattes W., and Beger R.D.
Archives of Toxicology. 2020, 27:1.

Computational Identification of Structural Factors Affecting the Mutagenic Potential of Aromatic Amines. Study Design and Experimental Validation.
Slavov S., Stoyanova-Slavova I., Mattes W., Beger R., and Brüschweiler B.
Archives of Toxicology. 2018, 92: 2369.

Why are Most Phospholipidosis Inducers also hERG Blockers?
Slavov S., Stoyanova-Slavova I., Li S., Zhao J., Huang R., Xia M., and Beger R.
Archives of Toxicology. 2017, doi: 10.1007/s00204-017-1995-9.

3D-SDAR Modeling of hERG Potassium Channel Affinity: A Case Study in Model Design and Toxicophore Identification.
Stoyanova-Slavova I.B., Slavov S.H., Buzatu D.A., Beger R.D., and Wilkes J.G.
Journal of Molecular Graphics and Modelling. 2017, 72: 246.

Feature Selection from Mass Spectra of Bacteria for Serotyping Salmonella.disclaimer icon
Slavov S., Alusta P., Buzatu D.A., and Wilkes J.G.
Journal of Analytical and Applied Pyrolysis. 2016.

Rigorous 3‐Dimensional Spectral Data Activity Relationship Approach Modeling Strategy for ToxCast Estrogen Receptor Data Classification, Validation, and Feature Extraction.
Slavov S.H. and Beger R.D.
Environmental Toxicology and Chemistry. 2016, 9999: 1.

Computational Identification of a Phospholipidosis Toxicophore Using 13C and 15N NMR-Distance Based Fingerprints.
Slavov S.H., Wilkes J.G., Buzatu D.A., Kruhlak N.L., Willard J.M., Hanig J.P., and Beger R.D.
Bioorganic & Medicinal Chemistry. 2014, 22: 6706.

Partial Least Square and K‐Nearest Neighbor Algorithms for Improved 3D Quantitative Spectral Data–Activity Relationship Consensus Modeling of Acute Toxicity.
Stoyanova‐Slavova I.B., Slavov S.H., Pearce B., Buzatu D.A., Beger R.D., and Wilkes J.G.
Environmental Toxicology and Chemistry. 2014, 33: 1271.

Identification of a Metabolic Biomarker Panel in Rats for Prediction of Acute and Idiosyncratic Hepatotoxicity.
Sun J., Slavov S., Schnackenberg L.K., Ando Y., Greenhaw J., Yang X., Salminen W., Mendrick D.L., and Beger R.
Computational and Structural Biotechnology Journal. 2014, 10: 78.

Complementary PLS and KNN Algorithms for Improved 3D-QSDAR Consensus Modeling of AhR Binding.
Slavov S.H., Pearce B.A., Buzatu D.A., Wilkes J.G., and Beger R.D.
Journal of Cheminformatics. 2013, 5: 47.

13C NMR-Distance Matrix Descriptors: Optimal Abstract 3D Space Granularity for Predicting Estrogen Binding.
Slavov S.H., Geesaman E.L., Pearce B.A., Schnackenberg L.K., Buzatu D.A., Wilkes J.G., and Beger R.D.
Journal of Chemical Information and Modeling. 2012, 52: 1854.

A Computational Study of the Binding of 3-(Arylidene) Anabaseines to Two Major Brain Nicotinic Acetylcholine Receptors and to the Acetylcholine Binding Protein.
Slavov S.H., Radzvilovits M., LeFrancois S., Stoyanova-Slavova I.B., Soti F., Kem W.R., and Katritzky A.R.
European Journal of Medicinal Chemistry. 2010, 45: 2433.

Novel Carboxamides as Potential Mosquito Repellents.
Katritzky A.R., Wang Z., Slavov S., Dobchev D.A., Hall C.D., Tsikolia M., Bernier U.R., Elejalde N.M., Clark G.G., and Linthicum K.J.
Journal of Medical Entomology. 2010, 47: 924.

Quantitative Correlation of Physical and Chemical Properties with Chemical Structure: Utility for Prediction.
Katritzky A.R., Kuanar M., Slavov S., Hall C.D., Karelson M., Kahn I., and Dobchev D.A.
Chemical Reviews. 2010, 110: 5714.

Correlation of the Photolysis Half-Lives of Polychlorinated Dibenzo-P-Dioxins and Dibenzofurans with Molecular Structure.
Katritzky A.R., Slavov S.H., Stoyanova-Slavova I.B., and Karelson M.
The Journal of Physical Chemistry A. 2010, 114: 2684.

QSAR Modeling, Synthesis and Bioassay of Diverse Leukemia RPMI-8226 Cell Line Active Agents.
Katritzky A.R., Girgis A.S., Slavov S., Tala S.R., and Stoyanova-Slavova I.
European Journal of Medicinal Chemistry. 2010, 45: 5183.

Quantitative Structure–Activity Relationship (QSAR) Modeling of EC50 of Aquatic Toxicities for Daphnia Magna.
Katritzky A.R., Slavov S.H., Stoyanova-Slavova I.S., Kahn I., and Karelson M.
Journal of Toxicology and Environmental Health, Part A. 2009, 72: 1181.

Legitimate Utilization of Large Descriptor Pools for QSPR/QSAR Models.
Katritzky A.R., Dobchev D.A., Slavov S., and Karelson M.
Journal of Chemical Information and Modeling. 2008, 48: 2207.

QSAR Modeling of the Antifungal Activity Against Candida Albicans for a Diverse Set of Organic Compounds.
Katritzky A.R., Slavov S.H., Dobchev D.A., and Karelson M.
Bioorganic & Medicinal Chemistry. 2008, 16: 7055.

QSAR Trout Toxicity Models on Aromatic Pesticides.
Slavov S., Gini G., and Benfenati E.
Journal of Environmental Science and Health Part B. 2008, 43: 633.

Synthesis and Bioassay of Improved Mosquito Repellents Predicted from Chemical Structure.
Katritzky A.R., Wang Z., Slavov S., Tsikolia M., Dobchev D., Akhmedov N.G., Hall C.D., Bernier U.R., Clark G.G., and Linthicum K.J.
Proceedings of the National Academy of Sciences. 2008, 105: 7359.

QSPR Modeling of UV Absorption Intensities.
Katritzky A.R., Slavov S.H., Dobchev D.A., and Karelson M.
Journal of Computer-Aided Molecular Design. 2007, 21, 371.

Quantitative Structure-Activity Relationship Analysis of the Substituent Effects on the Binding Affinity of Derivatives of Trimetazidine.
Slavov S., Djunlieva M., Ilieva S., and Galabov B.
Arzneimittelforschung. 2004, 54: 9.


Contact Information
Svetoslav Slavov
(870) 543-7121
Expertise
Expertise
Approach
Domain
Technology & Discipline
Toxicology
Back to Top